Abstract:BACKGROUND & OBJECTIVE Matrix metalloproteinases (MMPs) might be involved in invasion and metastasis of tumors by degrading extracellular matrix (ECM) and basement membrane (BM). The 5A or 6A single nucleotide polymorphism (SNP) at the -1 171 bp site of promoter region of MMP-3 may modify the transcription and local expression of MMP-3. This study was to investigate correlation of the MMP-3 SNP with genetic susceptibility and lymph node metastasis of non-small cell lung cancer (NSCLC). METHODS Genotypes of the MMP-3 SNP of 173 NSCLC patients and 350 healthy controls were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). RESULTS Distributions of the MMP-3 genotypes in both NSCLC patients and healthy controls were accorded with Hardy-Weinberg equilibrium (P>0.05). Frequencies of the 6A/6A, 5A/6A, and 5A/5A genotypes were 65.3%, 30.6%, and 4.1% in NSCLC patients, and 67.7%, 30.0%, and 2.3% in healthy controls, whereas frequencies of the 6A and 5A alleles were 79.3% and 20.7% in NSCLC patients, and 82.7% and 17.3% in healthy controls. The overall genotype and allelotype distributions among NSCLC patients and healthy controls were similar (P>0.05). However, stratified analysis found that frequency of the 5A allele was significantly higher in smoking patients than in healthy smokers (21.0% vs. 12.9%, P=0.03). Therefore, smokers with the 5A/6A or 5A/5A genotype have higher risk of developing NSCLC [age and sex adjusted odds ratio (OR) =2.07, 95% confidence interval (CI) =1.13-3.78]. When stratified by pathologic types, no significant difference in MMP-3 genotype or allelotype distribution between adenocarcinoma patients, squamous carcinoma patients and healthy controls was shown. When further stratified by lymphatic metastasis status, frequencies of the 5A allele and the 5A/5A genotype were significantly higher in NSCLC patients with lymphatic metastasis than in NSCLC patients without lymphatic metastasis (22.8% vs. 11.8%, P=0.02u 8.6% vs. 0%, P=0.02). Thus, NSCLC patients with the 5A/5A genotype have higher risk of lymphatic metastasis than NSCLC patients with the 6A/6A genotype (OR=12.38, 95% CI=0.76-202.13). CONCLUSIONS The 5A allele of MMP-3 might be associated with the increased susceptibility to NSCLC among smokers. The 5A homozygote might increase the risk of lymphatic metastasis in NSCLC patients.

[Correlations of Polymorphisms in Matrix Metalloproteinase-3 and -7 Promoters to Susceptibility to Brain Astrocytoma].

Polymorphisms in Matrix Metalloproteinase-1 and 9 Promoters and Susceptibility to Adult Astrocytoma

Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China

Association Between the Functional Polymorphism in the Matrix Metalloproteinase-7 Promoter and Susceptibility to Adult Astrocytoma

Single Nucleotide Polymorphisms of Matrix Metallopeptidase 3 and Risk of Gliomas in a Chinese Han Population

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

No Association Between the Polymorphisms in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Promoter Regions and Colorectal Cancer in Chinese

Association of Matrix Metalloproteinase‐2 and ‐9 Promoter Polymorphisms with Colorectal Cancer in Chinese

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter is Associated with Colorectal Cancer.

The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Breast Cancer.

Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.

Polymorphisms in the Promoter Regions of Matrix Metalloproteinases 1 and 3 and Cancer Risk: A Meta-Analysis of 50 Case-Control Studies

Polymorphisms in the MMP1 and MMP3 Promoter and Non-Small Cell Lung Carcinoma in North China.

[Correlation of Matrix Metalloproteinase-3 Polymorphism to Genetic Susceptibility and Lymph Node Metastasis of Non-Small Cell Lung Cancer].

Meta-Analysis of Associations Between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases and the Risk of Colorectal Cancer

The Rs522616 Polymorphism in the Matrix Metalloproteinase-3 (Mmp-3) Gene is Associated with Sporadic Brain Arteriovenous Malformation in A Chinese Population

Association of Matrix Metalloproteinase-3 -1171(5A>6A) Polymorphism with Cancer Risk: a Meta-Analysis of 41 Studies.

Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.

The Association of Matrix Metalloproteinase-8 Promoter Genotypes in Breast Cancer

Variations in Matrix Metalloproteinase-1, -3, and -9 Genes and the Risk of Acute Coronary Syndrome and Coronary Artery Disease in the Chinese Han Population.

Allelic Variation of the MMP3 Promoter Affects Transcription Activity Through the Transcription Factor C-MYB in Human Brain Arteriovenous Malformations